CD44 and cancer: Among all the 37 patients who tested positive for CTCs, the expression of CD44+, a common surface marker for CSCs in many cancers including HCC [145], was observed in all the stages of HCC, indicating that CTCs with these three markers had a cancer stemness phenotype [33].